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Abstract
Introduction
Impaired fasting glucose (IFG) often progresses to type 2 
diabetes. Given the severity and prevalence of this disease, 
primary prevention is important. Intensive lifestyle coun-
seling interventions have delayed or prevented the onset 
of type 2 diabetes, but it is not known whether less inten-
sive, more easily replicable efforts can also be effective.
Methods
In  a  lifestyle  intervention  study  designed  to  reduce 
risks for type 2 diabetes, 200 American Indian women 
without  diabetes,  aged  18  to  40  years,  were  recruited 
from an urban community without regard to weight or 
IFG  and  block-randomized  into  intervention  and  con-
trol groups on the basis of fasting blood glucose (FBG). 
Dietary and physical activity behaviors were reported, 
and  clinical  metabolic,  fitness,  and  body  composition 
measures were taken at baseline and at periodic follow-
up through 18 months. American Indian facilitators used 
a group-discussion format during the first 6 months to 
deliver a culturally influenced educational intervention 
on healthy eating, physical activity, social support, and 
goal setting. We analyzed a subset of young American 
Indian women with IFG at baseline (n = 42), selected 
from both the intervention and control groups.
Results
Among the women with IFG, mean FBG significantly 
decreased from baseline to follow-up (P < .001) and con-
verted to normal (<5.6 mmol/L or <100 mg/dL) in 62.0% 
of the 30 women who completed the 18-month follow-up, 
irrespective  of  participation  in  the  group  educational 
sessions. Other improved metabolic values included sig-
nificant decreases in mean fasting blood total cholesterol 
and low-density lipoprotein cholesterol levels. The women 
reported significant overall mean decreases in intake of 
total energy, saturated fat, total fat, total sugar, sweet-
ened beverages, proportion of sweet foods in the diet, and 
hours of television watching.
Conclusion
Volunteers with IFG in this study benefited from learn-
ing their FBG values and reporting their dietary patterns; 
they made dietary changes and improved their FBG and 
lipid profiles. If confirmed in larger samples, these results 
support periodic dietary and body composition assessment, 
as well as glucose monitoring among women with IFG.
Introduction
Impaired  fasting  glucose  (IFG)  left  unattended  often 
progresses to type 2 diabetes (1-4). With the alarming rise 
in type 2 diabetes in the United States and internation-
ally, and with younger ages at onset (5,6), it is increas-
ingly urgent that we identify and assist people with IFG 
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in lowering blood glucose levels before insulin resistance 
leads to beta cell failure.
IFG is defined as fasting blood glucose (FBG) of 5.6–6.9 
mmol/L  (100–125  mg/dL)  (1).  On  the  basis  of  this  defi-
nition,  the  1999–2002  National  Health  and  Nutrition 
Examination Survey (NHANES) indicated a 9.3% preva-
lence of diabetes (diagnosed and undiagnosed) and 26.0% 
prevalence of IFG among U.S. adults aged 20 years and 
older (7). In this same survey, 8.2% of women aged 20 to 
39 and 7.3% of girls aged 12 to 19 had IFG (6).
Rates  of  type  2  diabetes  are  high  among  American 
Indians  and  Alaska  Natives  compared  with  other  U.S. 
groups (8). NHANES did not report national estimates of 
IFG specifically for American Indians (6,7), but a study of 
1056 Alaska Eskimos aged 18 and older found that 15.6% 
of all adults and 13.9% of women had IFG (9). The Inter-
Tribal Heart Project found 16.8% of 1376 American Indian 
adults (aged 25 and older) without diabetes had FBG val-
ues of 6.1–6.9 mmol/L (110–125 mg/dL) (10).
Risk factors for IFG, impaired glucose tolerance (IGT), 
and  type  2  diabetes  include  obesity  or  overweight, 
sedentary lifestyle, family history, and consumption of 
foods  high  in  saturated  fat  and  added  sugars  (11-13). 
In 2002–2004, an estimated 33.0% of American Indian 
and Alaska Native women were obese (body mass index 
[BMI]  ≥30.0  kg/m2)  and  23.3%  were  overweight  (BMI 
25.0–29.9  kg/m2),  compared  with  23.2%  and  27.3%  of 
U.S.  women  overall,  respectively  (5).  An  estimated 
45.5%  of  American  Indian  and  Alaska  Native  women 
report no leisure-time physical activity, compared with 
39.8%  of  U.S.  women  overall  (5).  Intensive  individual 
lifestyle  counseling  interventions  among  adults  older 
than 50 years with IGT have resulted in dietary changes, 
increased  physical  activity,  and  weight  loss  and  have 
delayed or prevented the onset of type 2 diabetes (4,13). 
What is not known is whether less intensive, more easily 
replicable lifestyle interventions can reduce risk for type 
2 diabetes among young adults (14).
The purpose of this study was to conduct an analysis of 
results among a small subset of women with IFG at base-
line who participated in a lifestyle intervention study with 
an 18-month follow-up. The larger study tested efficacy of a 
low-intensity lifestyle intervention to reduce risks for type 
2 diabetes among 200 urban American Indian women aged 
18 to 40 recruited from the general community without 
regard to risk factors for type 2 diabetes. Results of the 
randomized controlled trial are reported elsewhere (15).
Methods
Participants
American  Indian  women  were  recruited  from  June 
2002 through June 2004 from a southwestern U.S. city 
to participate in a randomized controlled trial to test the 
effectiveness of a healthy lifestyle intervention in reducing 
risks for type 2 diabetes. Participants were recruited via 
word of mouth; flyers posted at outpatient clinics, colleges, 
and major employers; and local media. Eligibility criteria 
included  self-identification  as  American  Indian,  female, 
aged 18–40 at baseline, without diabetes, planning to stay 
in the local area for 2 years, not pregnant, and not planning 
a pregnancy in the next 2 years. Human subjects approval 
was obtained from the University of New Mexico Health 
Sciences Center Human Research Review Committee and 
the  local  Indian  Health  Service  clinic.  Potential  volun-
teers were screened over the phone for eligibility; eligible 
women were invited to an in-person meeting for further 
explanation of the study and to obtain written informed 
consent. To be included in the study, the 200 women had to 
be without diabetes at baseline as measured by FBG <7.0 
mmol/L (<126 mg/dL) (1).
Randomization
The 200 eligible volunteers were block-randomized by 
FBG level into 2 groups of 100 women each (intervention 
and control) to ensure equivalent representation among 
the 2 groups. The intervention was implemented between 
the baseline and 6-month clinic measures, with follow-up 
clinic measurements at 12 and 18 months. Women from 
the control group completed the 4 clinic measurements at 
baseline and at 6, 12, and 18 months and were then offered 
and provided the same intervention.
Intervention
A multidisciplinary and multiethnic team of American 
Indian  and  non-Indian  health  professionals  and  com-
munity  members  drafted  a  5-session  curriculum  and 
pilot-tested  it  with  members  of  the  target  community 
(16).  The  healthy  lifestyles  intervention  consisted  of 
discussion-format group sessions that took place once a 
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staff. The intervention included written and oral didactic 
material with culturally appropriate graphics, and par-
ticipation in small-group discussions. The first session 
covered diabetes-related definitions and the importance 
of physical activity. Subsequent sessions promoted eat-
ing  more  vegetables  and  fruits  and  less  saturated  fat 
and added sugar, setting goals, getting social support for 
behavior change, and maintaining behavior change.
Measurements
Trained dietetics and nursing staff conducted the base-
line and follow-up clinical measurements at the University 
of New Mexico Health Sciences Center outpatient General 
Clinical Research Center (funded by the National Institutes 
of Health), from June 2002 through February 2006. After 
an overnight fast, volunteers had their blood drawn via 
venipuncture and analyzed for glucose, insulin, and lipids. 
Insulin  sensitivity  was  estimated  by  using  the  quanti-
tative  insulin  sensitivity  check  index:  1/(log  insulin  + 
log glucose) (17). Blood chemistry analysis methods are 
described elsewhere (18). Participants’ height, weight, and 
hip  and  waist  circumferences  were  measured  by  using 
standard methods. Body composition was measured with 
Quantum bioelectrical impedance software (RJL Systems, 
Clinton Township, Michigan), using a prediction equation 
validated with American Indian women (19). After each 
clinic visit, each participant was informed in writing of 
her results and the expected and at-risk ranges for FBG, 
lipids, body composition, and blood pressure. Participants 
were encouraged to share these results with their primary 
care providers.
The women also reported previous 6-month food and bev-
erage intake on the Block Food Frequency Questionnaire 
(20) plus a supplemental form on Southwestern foods pre-
viously validated in New Mexico (21). A 24-hour dietary 
recall was also administered at each clinic visit. History of 
gestational diabetes and family history of type 2 diabetes 
was self-reported as yes/no at the first clinic visit.
Self-reported physical activity over the previous year at 
baseline, and over the previous 6 months during the study 
period,  was  assessed  by  using  the  Modifiable  Activity 
Questionnaire (22); this tool has been tested for reliability 
and validity among Pima Indian adults. Predicted peak 
oxygen consumption was obtained during a submaximal 
bicycle ergometer test with the YMCA protocol (23).
Statistical analyses
We conducted analyses for the subset of 42 women with 
IFG at baseline (FBG ≥5.6 mmol/L or ≥100 mg/dL), 19 of 
whom were in the intervention group and 23 in the control 
group. Mean changes at follow-up visits were obtained by 
subtracting each woman’s baseline value from the value 
at each subsequent time point; differences were analyzed 
by using one-way repeated measures analyses of variance 
(RM  ANOVA).  Post  hoc  comparisons  of  mean  changes 
at each time point from baseline were obtained by using 
paired t tests. Initially, group by visit (2x4) RM ANOVA 
were  conducted  to  detect  possible  differences  in  means 
due to intervention. However, the sample was too small 
to  detect  between-group  differences  (data  not  shown). 
Therefore, we conducted pooled analyses that disregarded 
intervention group status. 
Results
Baseline
Of the 200 eligible women, 42 (21.0%) had IFG at base-
line. Baseline results comparing the 42 women with IFG 
and the 158 with normal FBG are reported elsewhere (18). 
At  baseline,  women  with  IFG  were  significantly  older, 
with a higher mean BMI, waist circumference, percent-
age of body fat, fasting insulin, triglycerides, and diastolic 
blood pressure, and lower mean high-density lipoprotein 
(HDL) cholesterol than women with normal FBG (data not 
shown). Table 1 shows the baseline characteristics of the 
42 women with IFG.
Follow-up
Retention at the 18-month clinic visit was 30 (71.4%) 
of the original 42 women with IFG. Reasons for dropout 
included moving out of the area, pregnancy, or perception 
of being too busy to continue.
Fasting blood glucose
Table 2 and Table 3 show mean baseline values and 
mean changes in metabolic, body composition, dietary, and 
physical activity measurements at follow-up. Women with 
IFG had significant mean reductions in FBG over time (P 
< .001) (Table 2). Their FBG at 6 months was a mean of 
3.7% lower than baseline FBG, and at 12 and 18 months, 
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respectively, was 3.2% and 6.6% lower. Of the women who 
completed follow-up, 62% converted to normal FBG by 18 
months.  Insulin  sensitivity  remained  stable  throughout 
the study despite reductions in FBG (data not shown).
Lipids
Mean lipid profiles were within normal ranges at base-
line. Nevertheless, total cholesterol and low-density lipo-
protein (LDL) cholesterol significantly decreased among 
all  women  with  IFG  over  time.  Changes  in  HDL  over 
time were not significant. By 12 months there was a 6.3% 
increase in HDL among the women with IFG, but by 18 
months the increase from baseline was 4.5% of the base-
line value (P = .07).
Weight and waist circumference
Although  overall  mean  changes  in  BMI,  weight,  and 
waist circumference were small (Table 2), more than half 
of the women weighed less at each follow-up visit than they 
did at baseline (51.5% at 6 months, 51.5% at 12 months, 
and 53.3% at 18 months) (data not shown). Among women 
who lost weight, the average percentage of baseline weight 
lost was 3.5% (SD, 3.3%) at 6 months, 6.0% (SD, 5.8%) at 
12 months and 6.2% (SD, 4.9%) at 18 months. Women who 
lost weight at 18 months reduced their FBG by an average 
of 12.0% of baseline value at 18 months, and women with-
out weight loss at 18 months had a 1.1% reduction in FBG 
(P = .002). At 18 months, 54.8% of the women lost waist 
circumference compared to baseline, with a mean reduc-
tion among these women of 5.4% (SD, 4.2%) of baseline 
waist circumference (data not shown).
Other changes at follow-up
Over time women with IFG significantly decreased mean 
total energy intake, total fat intake, saturated fat intake, 
total sugar intake, proportion of sweet foods in the diet, 
and intake of sweetened beverages (Table 3). Both mean 
total fat and saturated fat intakes decreased by approxi-
mately one-fourth at 18 months. Fitness levels from the 
bicycle test remained stable throughout the study, as did 
blood  pressure.  Mean  number  of  hours  spent  watching 
television significantly decreased over time. The average 
reported amount of time spent in leisure physical activity 
was 4.4 hours (SD, 3.8 hours) per week at baseline and did 
not change significantly over time. However, 43.3% of the 
women who completed follow-up reported physical activ-
ity at 18 months that totaled an increase of more than 2.0 
hours/week from baseline (data not shown).
Discussion
Implications for screening and periodic follow-up
Results  from  this  post  hoc  subset  analysis  show  that 
once these volunteers learned they had IFG, many were 
successful  in  making  dietary  changes  that  resulted  in 
weight loss, lower FBG, and better lipid profiles, regard-
less  of  whether  they  participated  in  the  low-intensity 
intervention  or  just  the  follow-up  clinical  measures.  Of 
the  women  who  completed  follow-up,  62%  converted  to 
normal FBG by 18 months. The FBG screening and peri-
odic follow-up visits appear to have been an unintended 
intervention. Seeing a research dietitian at each clinic visit 
may have raised the women’s awareness of their dietary 
patterns  and  body  composition.  Women  received  their 
clinical results after each visit and thus could track their 
progress over the follow-up period. This information was 
shared with participants because of the importance of full 
disclosure to this high-risk group. These results suggest 
that periodic follow-up that includes more than just blood 
glucose  screening  may  improve  metabolic  control  more 
than does follow-up with blood glucose screening alone. 
Although these findings need to be confirmed in larger 
samples,  they  imply  that  interventions  should  include 
regular  dietary  assessment  and  measurement  of  body 
composition, in addition to glucose monitoring.
The American Diabetes Association (ADA) recommends 
FBG screening or an oral glucose tolerance test every 3 
years to detect IFG, IGT, or undiagnosed diabetes in all 
adults aged 45 years and older, especially if overweight, 
and more frequent screening tests if additional risk fac-
tors are present (1). Among adults younger than 45, ADA 
recommends  screening  those  who  are  overweight  (BMI 
≥25.0 kg/m2) and have additional risk factors for diabetes, 
including physical inactivity, family history of diabetes, 
belonging to an ethnic group with a high prevalence of dia-
betes, history of gestational diabetes, high blood pressure, 
low HDL cholesterol, or high triglycerides (1).
The extent to which ADA screening and follow-up are 
implemented among American Indians is a concern, since 
this  population  has  a  high  rate  of  type  2  diabetes  and 
its complications. Participants’ comments and questions 
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Indian women had not previously been screened for type 
2 diabetes. Many tribes around the country have recently 
initiated  or  expanded  diabetes  prevention  services  in 
tribal communities. A recent telephone interview study in 
Montana found 72% of 428 randomly selected American 
Indian adults aged 18 to 44 years living on or near a res-
ervation recalled having a blood glucose screening for dia-
betes within the past 3 years (24), but data on the extent 
of screening and monitoring for urban American Indian 
adults are lacking.
Urban American Indians are a growing population that 
is under-served for preventive health care; in the 2000 
U.S. census, 61% (1.5 million) of Americans who reported 
American Indian or Alaska Native ethnicity alone lived 
in urban areas (25). Of these, only 34% resided in coun-
ties with a federally funded urban outpatient clinic serv-
ing American Indians, and these clinics nearly lost their 
federal funding in a recent budget cycle (25). ADA recom-
mends that FBG or IGT screening be conducted only as 
part of a health care office visit (1). Fully implementing 
ADA screening recommendations among urban American 
Indian and other high-risk adults presents many chal-
lenges, particularly 1) identifying a health care system 
that has the infrastructure and ongoing funding to reach 
these  residents  and  2)  providing  follow-up  monitoring 
(and ideally, support for lifestyle changes) after diagnos-
ing adults with IFG or IGT, which can carry emotion-
ally laden or negative labels. However, added impetus 
to resolve these challenges may come from the growing 
body of evidence that IFG and IGT (before progression 
to type 2 diabetes) may increase the risk for hyperten-
sion,  abnormal  blood  lipid  profiles,  and  cardiovascular 
diseases (26,27).
During study design, the research team decided to dis-
close and explain results of each clinic visit in writing to 
participants because of the seriousness of type 2 diabetes 
and  potential  to  prevent  or  delay  the  disease,  despite 
potential  contamination  of  the  research  findings.  This 
disclosure likely contributed to the lack of significant dif-
ference between the control and intervention groups. If 
findings from this study are confirmed in larger samples, 
periodic follow-up that promotes specific client awareness 
of clinical results, along with detailed dietary assessments, 
may be an effective low-intensity intervention with high-
risk women. Because of the ethical principle of not with-
holding effective interventions, researchers in future stud-
ies might then be ethically bound to disclose future study 
participants’ blood glucose and other markers.
Low-intensity vs high-intensity interventions
The  major  clinical  trials  that  used  intense  lifestyle 
interventions with frequent participant contact produced 
changes in physical activity that this study did not and 
found larger mean physiologic changes and similar mean 
self-reported  dietary  changes  (4,11,13,28,29).  The  high 
baseline average reported amount of time spent in leisure 
physical  activity  of  4.4  hours  (SD,  3.8  hours)  per  week 
may partially explain the lack of significant increase in 
physical activity here. More intense interventions may be 
needed to stimulate increased participation in moderate- 
and vigorous-intensity activity (30).
At the end of the 3-year Diabetes Prevention Program 
(DPP)  lifestyle  intervention  study,  participants  had 
attended an average of 50.3 sessions (SD, 21.8 sessions), 
and 27% of adults younger than 45 met the 7% weight 
loss goal, compared with 63% of those 65 and older (29). 
Weight loss was not a direct aim of the intervention in the 
present study, so no target weight loss goal was identified. 
However,  20%  of  women  who  completed  follow-up  lost 
at least 7.0% of baseline weight at 18 months (data not 
shown). Lipid profile improvements were smaller in this 
study than those reported in a review of intense lifestyle 
interventions (13), but mean baseline lipid profiles were 
near normal in the present study. 
Lower  fat  intake,  particularly  saturated  fat  intake, 
may protect against development of type 2 diabetes (11). 
Baseline dietary fat and saturated fat intakes were simi-
lar in the present study to those of the American Indian 
women in the DPP and other studies (31,32). At 1 year, 
the 45 American Indian women in the DPP lifestyle inter-
vention reported a reduction in percentage of energy from 
total fat of 4.3% (SD, 6.8%), with a concomitant reduction 
in percentage of energy from saturated fat of 2.0% (SD, 
3.4%). We found greater reductions in fat and saturated 
fat intake in the present study at 12 months, but weight 
loss was of lower magnitude.
Intake of sweetened beverages is linked to weight gain 
and  to  development  of  type  2  diabetes  (11,12,33).  The 
general U.S. population has increased its intake of these 
beverages over the past 20 years (34). Although we did 
not  find  national  results  for  American  Indian  women 
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specifically, other studies indicate this population also has 
a  high  intake  of  sweetened  beverages  (35,36).  Among  a 
convenience sample of 203 urban American Indian women 
in Minnesota (mean age 33.8 years), 66.7% reported drink-
ing at least 1 soda with sugar per day, and half reported 
drinking Kool-Aid daily (37). At 1-year follow-up, the 45 
American Indian women in the lifestyle intervention arm 
of the DPP study reduced their intake of sweets by a mean 
of 7.3 total servings/week (SD, 17.4 servings/week). In the 
present study, at 1 year total percentage of sweets in the 
diet decreased 3.7% (SD, 10.5%) and intake of sweetened 
beverages decreased 7.2 ounces/day (SD, 20.1 ounces/day).
A review of 7 low-intensity community-based lifestyle 
interventions  designed  to  reduce  risk  for  type  2  diabe-
tes among adults (14) found increased knowledge about 
physical activity and nutrition, and increased self-reported 
physical  activity  levels.  Two  of  the  interventions  also 
showed  decreased  waist  circumference  or  BMI.  Most 
did  not  include  clinical  measures  other  than  weight. 
Interventions varied, lasting from 6 to 16 months, but most 
involved walking groups and/or group educational sessions 
and cooking demonstrations. Providing structured physi-
cal  activities  likely  could  have  benefited  women  in  the 
present study.
Limitations
This subset analysis from a larger study has several lim-
itations. Statistical power was not great enough to detect 
differences in mean changes between women with IFG in 
the intervention and control groups because of the small 
sample size and the wide variability in the women’s dietary 
and metabolic values. Had this study been designed after 
DPP results were known, low-risk women might well have 
been  excluded,  creating  a  larger  sample  size  of  women 
with IFG. A tendency to self-report intervention-related 
and  socially  desirable  dietary  changes  has  been  well- 
documented (38), but the reported dietary changes here 
were supported by actual weight loss. Previous authors 
have  suggested  American  Indian  dietary  patterns  may 
appear similar to each other and to the overall U.S. popu-
lation because of incomplete recording of traditional foods 
or  seasonal  foods  consumed  at  ceremonies,  and  other 
factors (39). To minimize these issues we used a supple-
mental set of questions to capture traditional foods and 
collected data at different times of the year. The study 
volunteers may not be representative of other similarly 
aged urban American Indian women or other populations. 
Participants may have volunteered because of family his-
tory of type 2 diabetes or other concerns about their health 
status as well as readiness to make lifestyle changes. A 
further limitation is that a single FBG measurement is 
not as accurate an estimate of impairment in the body’s 
processing of glucose as are repeated FBG measurements 
or the 2-hour oral glucose tolerance test. However, the cur-
rent study design and resources did not allow for repeat 
FBG testing at each measurement period.
Conclusion
The DPP and other lifestyle interventions that involve 
frequent  contact  with  high-risk  adults  are  effective,   
but  such  intensive  repeated  one-on-one  or  even  group 
counseling  is  expensive  and  challenging  to  replicate  in 
communities  and  in  typical  health  care  settings  (40). 
It is encouraging that many of the women with IFG in 
the  present  study  made  dietary  changes,  lost  weight, 
improved lipid profiles, and converted to normal FBG after 
infrequent FBG monitoring and other clinical and dietary 
assessments.  We  hope  the  experiences  of  this  group  of 
women will inspire other researchers to conduct tests with 
larger samples to determine whether periodic, low-inten-
sity, fully disclosed monitoring of dietary patterns, body 
composition, FBG, and other markers can help high-risk 
adults delay or prevent the onset of type 2 diabetes.
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Baseline Value, 
Mean (SD) 
n = 42
Baseline Value, 
Mean (SD) 
n = 42Tables
Table 1. Baseline Participant Characteristics Among 42 Urban American Indian Women With Impaired Fasting Glucose From 
a Southwestern U.S. City, 2002–2004
Characteristic Baseline Value
Mean age, y (SD) 3. (.0)
Body mass index (BMI) category, n (%)
Obese (BMI ≥30.0 kg/m2) 30 (7.)
Overweight (BMI 25.0-29.9 kg/m2) 0 (23.8)
BMI <25.0 kg/m2 2 (.8)
Family history of type 2 diabetes, n (%) 33 (80.5)
History of gestational diabetes, n (%) 3 (7.)
Education, n (%)
College graduate  (.2)
-3 y college 23 (2.2)
Graduated high school  (.2)
Not high school graduate 2 (5.)
Have children, n (%) 30 (7.)
Table 2. Mean Changesa in Metabolic and Body Composition Measures at Follow-Up Among 42 Urban American Indian 
Women With Impaired Fasting Glucose at Baseline in a Southwestern U.S. City, 2002–2006 
Characteristic
Baseline Value, 
Mean (SD) 
n = 42
6-Month Change 
From Baseline, 
Mean (SD) 
n = 33
12-Month Change 
From Baseline, 
Mean (SD) 
n = 33
18-Month Change 
From Baseline, 
Mean (SD) 
n = 30
Overall Change 
Over Time 
P Valueb
Fasting blood glucose, mmol/L  5.87 (0.32)  -0.22 (0.30)c  -0.9 (0.50)c  -0.39 (0.0)c  <.00
Diastolic blood pressure, mm Hg 7.8 (9.) -.9 (8.3) -.0 (0.3) -. (8.2) .5
Systolic blood pressure, mm Hg 9.3 (.) +0.0 (.0) -3.8 (2.8) -2. (2.5) .2
Body mass index, kg/m2 3. (7.0) -0.2 (.7) -0.5 (2.7) -0.2 (2.8) .0
Weight, kg 88. (7.5) -0.5 (.5) -. (.9) -0.5 (7.2) .7
Waist circumference, cm 03.3 (5.5) -. (.) -.9 (.3) -2.2 (5.8)c .23
Body fat, % 3.85 (.00) +0.2 (.70) +0.22 (2.03) +0.8 (2.2) .8
Triglycerides, mmol/L .8 (0.8) -0.2 (0.5) -0.8 (0.3) -0. (0.7) .0
Total fasting cholesterol, mmol/L .2 (0.8) -0.2(0.58)c -0.2 (0.58)c -0.0 (0.50) .03
LDL, mmol/L 2.8 (0.2) -0.7 (0.8) -0.23 (0.5)c -0.09 (0.) .009
HDL, mmol/L . (0.20) +0.02 (0.) +0.07 (0.5) +0.05 (0.9) .07
 
LDL indicates low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol. 
a Follow-up value minus baseline value for each woman summed and averaged. 
b Repeated measures analyses of variance to test for change over all  clinic visits. 
c Significant difference from baseline value per paired t test, P < .05.
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Table 3. Mean Changesa in Dietary Intake, Activity, and Fitness at Follow-Up Among 42 Urban American Indian Women With 
Impaired Fasting Glucose at Baseline in a Southwestern U.S. City, 2002–2006 
 Characteristic
Baseline Value, 
Mean (SD) 
n = 42
6-Month Change 
From Baseline, 
Mean (SD) 
n = 33
12-Month Change 
From Baseline, 
Mean (SD) 
n = 33
18-Month Change 
From Baseline, 
Mean (SD) 
n = 30
Overall Change 
Over Time 
P valueb
Total energy intake, kcal/day 2307. (97.) -39.2 (958.) -550.5 (83.2)c -55.5 (853.)c < .00
Total fat intake, g/day 00.0 (5.) -20.5 (.)c -20. (22.)c -2.2 (8.3)c .00
Saturated fat intake, g/day 3. (5.) -.2 (.) -. (.8)c -7.7 (.0)c .00
Proportion of sweet foods in diet, % .2 (7.0) -.7 (7.) -3.7 (0.5) -5.2 (7.)c .0
Total sugar intake, g/day .2 (.8) -37.3 (78.3)c -29.2 (77.9)c -2.2 (8.7) .03
Intake of sweetened beverages, 
oz/day
2.3 (20.0) -.32 (20.8)c -7.7 (20.)c -5.2 (30.3) .02
Peak VO2, L/min .99 (0.3) -0.3 (0.5) -0.0 (0.8) -0.5 (0.57) .2
Total leisure-time physical activity, 
h/wk
. (3.8) +0. (.) +0.3 (.) +0.7 (.7) .7
Television watching, h/day 2.3 (2.) -0. (2.) -0.9 (.9)c -0. (2.0) .03
 
VO2 indicates oxygen consumption. 
a Follow-up value minus baseline value for each woman summed and averaged.  
b Repeated measures analyses of variance to test for change over all  clinic visits. 
c Significant difference from baseline value per paired t test, P < .05.
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